Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice

T W Cotter, K H Ramsey, G S Miranpuri, C E Poulsen, G I Byrne, T W Cotter, K H Ramsey, G S Miranpuri, C E Poulsen, G I Byrne

Abstract

Mice (C57BL/6), treated with progesterone and infected intravaginally with the mouse pneumonitis strain of Chlamydia trachomatis (MoPn), acquired genital tract disease that ascended from the endocervix to the uterine horns, oviducts, and ovaries in a temporal fashion before the occurrence of spontaneous microbiological resolution by about 28 days after infection. Surprisingly, dissemination of MoPn in small numbers to draining lymph nodes, the peritoneal cavity, spleen, liver, kidneys, and lungs occurred in normal mice during the early stages of disease (7 to 14 days) in a portion of infected animals but resolved from these tissues, by microbiological criteria, prior to resolution of genital tract involvement. In contrast, gamma interferon knockout (IFN-gamma KO) mice exhibited dissemination of infection to a greater extent and for longer periods in a variety of tissues, and a portion of infected IFN-gamma KO mice failed to microbiologically resolve their genital tract disease. By comparison, C57BL/6 SCID mice uniformly failed to resolve their genital tract disease and exhibited high levels of dissemination to all tissues tested for extended (50-day) periods of times. Interestingly, although IFN-gamma KO mice failed to completely clear organisms from their genital tracts, they exhibited an attenuated infection indistinguishable from that of heterozygous littermates when challenged 112 days after primary infection. These data support a role for IFN-gamma in containing dissemination of MoPn from the genital tract to extragenital sites and in the microbiological resolution of infection. Data also indicate that IFN-gamma is not required for modulating reinfections, which normally follow a shorter and less dramatic course.

References

    1. Infect Immun. 1981 Mar;31(3):1161-76
    1. Infect Immun. 1997 Mar;65(3):1032-44
    1. Infect Immun. 1983 Dec;42(3):1152-8
    1. Infect Immun. 1985 Jun;48(3):847-9
    1. J Infect Dis. 1985 Dec;152(6):1275-82
    1. Infect Immun. 1988 May;56(5):1320-5
    1. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8932-5
    1. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4471-5
    1. J Reprod Fertil. 1992 May;95(1):31-8
    1. J Gen Microbiol. 1992 Aug;138 Pt 8:1707-15
    1. Infect Immun. 1992 Oct;60(10):4427-9
    1. Science. 1993 Mar 19;259(5102):1739-42
    1. Science. 1993 Mar 19;259(5102):1742-5
    1. J Exp Med. 1994 Apr 1;179(4):1367-71
    1. Infect Immun. 1994 May;62(5):2094-7
    1. Reg Immunol. 1993 Nov-Dec;5(6):317-24
    1. Trends Microbiol. 1994 Jul;2(7):235-42
    1. Infect Immun. 1994 Nov;62(11):5195-7
    1. J Immunol. 1994 Dec 1;153(11):5183-9
    1. J Leukoc Biol. 1994 Nov;56(5):565-70
    1. Nature. 1995 Feb 2;373(6513):427-32
    1. Microbiol Rev. 1994 Dec;58(4):686-99
    1. Infect Immun. 1995 May;63(5):1784-9
    1. Immunity. 1995 Jul;3(1):109-17
    1. Infect Immun. 1995 Sep;63(9):3302-8
    1. Infect Immun. 1995 Dec;63(12):4661-8
    1. Infect Immun. 1995 Dec;63(12):4704-14
    1. N Engl J Med. 1996 Apr 4;334(14):904-7
    1. Blood. 1996 Feb 15;87(4):1439-45
    1. Immunology. 1996 Jan;87(1):1-8
    1. Infect Immun. 1996 Sep;64(9):3916-9
    1. Infect Immun. 1996 Dec;64(12):4976-83
    1. Exp Parasitol. 1997 Feb;85(2):206-13
    1. J Immunol. 1983 Nov;131(5):2542-4

Source: PubMed

3
订阅